Navigation Links
Lung Cancer Evolves With Treatment, Study Finds
Date:3/23/2011

WEDNESDAY, March 23 (HealthDay News) -- A new study helps explain how some lung cancers become resistant to targeted drug therapy.

Researchers at the Massachusetts General Hospital Cancer Center analyzed tumor samples from 37 patients with non-small cell lung cancer, the leading cause of cancer death worldwide, and identified two new genetic changes associated with resistance.

They also confirmed resistance-related genetic changes identified in previous studies.

The MGH team also discovered that the cellular nature of some tumors changes in response to treatment and that genetic mutations associated with drug resistance can disappear after treatment is halted.

The findings highlight the importance of monitoring the molecular status of lung cancer tumors throughout the treatment process, the researchers said.

"It is really remarkable how much we oncologists assume about a tumor based on a single biopsy taken at one time, usually the time of diagnosis," lead author Dr. Lecia Sequist said in an MGH news release. "Many cancers can evolve in response to exposure to different therapies over time, and we may be blind to the implications of these changes simply because we haven't been looking for them."

"Our findings suggest that, when feasible, oncogene-driven cancers should be interrogated with repeat biopsies throughout the course of the disease," Sequist said. "Doing so could both contribute to greater understanding of acquired resistance and give caregivers better information about whether resumption of targeted therapy or initiation of a standard therapy would be most appropriate for an individual patient."

The study appears March 23 in the journal Science Translational Medicine.

More information

The American Cancer Society has more about non-small-cell lung cancer.

-- Robert Preidt

SOURCE: Massachusetts General Hospital, news release, March 23, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Statins make radiation more effective at curing prostate cancer
2. UT MD Anderson receives grant for study of acupuncture in cancer
3. Discovery in liver cancer cells provides new target for drugs
4. Tamoxifen May Offer Long-Term Heart, Cancer Protection
5. Jefferson clinical trial: Can a cholesterol drug prevent colon cancer?
6. Good news for meat lovers: Most ready-to-eat meat products contain very few cancerous compounds
7. Philanthropic pledge triples funds for TGen ovarian cancer research
8. Smoke-Free Environments Linked to Less Breast Cancer
9. The MMRF and John Theurer Cancer Center to host patient symposium
10. Does selenium prevent cancer? It may depend on which form people take
11. Malaria drug slows pancreatic cancer growth in mouse models
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung Cancer  Evolves With Treatment, Study Finds
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO Jay Southerland ... version at the International Roofing Expo in Orlando, Florida on February 17-19. , ... advanced weather technology in the hands of consumers, roofing contractors, manufacturers and distributors,” ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... and Video Remote Interpreting (VRI) within Healthcare, recently partnered with Heart City ... interpreting (VRI). , For nearly 23 years, Heart City Health Center has provided ...
(Date:2/10/2016)... Huntington, NY (PRWEB) , ... February 10, 2016 ... ... web-based compliance tracking solution, The Guard, to associations of medical professionals throughout the ... HIPAA compliance, including security risk assessments, policies and procedures, employee training, regulatory updates, ...
(Date:2/10/2016)... ... ... Emergency rooms provide emergency care to stabilize critical health issues, but emergency dental ... at risk of losing a tooth or their smiles. Dr. Marine Martirosyan, dentist ... include:, , Avulsed or knocked-out teeth , Dislodged ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Resolve Therapeutics, LLC, a clinical stage biopharmaceutical company ... of lupus and Sjogrens syndrome, today announced the ... in patients with systemic lupus erythematosus (SLE) with ... --> Data from a multicenter ... RSLV-132 in 32 subjects with SLE demonstrate the ...
(Date:2/10/2016)... NEW YORK , Feb. 10, 2016 ... clinical-stage biopharmaceutical company, announced today that it has filed ... Myeloid Leukemia and other cancers. --> ... of treating cancer by administration of Ceplene (histamine dihydrochloride) ... also provides methods of predicting the efficacy of Ceplene ...
(Date:2/10/2016)... A Worldwide Clinical Trials expert will ... Victoria Park Plaza in London , 24-25 ... and future advances for late phase research on Wednesday, 24 ... , associate director of project management at Worldwide, will focus ... regulations and standards in late phase research. ...
Breaking Medicine Technology: